Sale of 4,788 shares at $0.344 per share.
Reporting Person Abate Kristin · Officer Title Chief Accounting Officer · Transaction Code S
Traded Oct 16, 2026 · Disclosed Oct 19, 2026
Source: SEC Form 4 · 0001193125-26-425227 · filed 2026-10-19 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Karyopharm Therapeutics Inc. (KPTI)." Disclosed 2026-10-19. https://desqlong.com/cards/0001193125-26-425227-1 (retrieved 2026-10-20).